However, after treatment with metformin and prednisone, expression of CXCL12 and CXCR4 in the DMD model mice was reduced, suggesting that CXCL12 may be a potential therapeutic target for DMD. The gene discussed is CXCL12; the disease is Duchenne muscular dystrophy.